Sopharma AD (the “Company”) notifies that for August 2014 the Company recorded a decrease of sales revenues of 11% compared to the same period of 2013, including 9% increase of domestic sales and 19% decrease of export sales.
During the past eight months Sopharma AD recorded a decrease of sales revenues of 6%, including 3% increase of domestic sales and 9% decrease of export sales compared to 2013.
SOPHARMA AD (the “Company”) hereby informs that from 4 September2014 up to and including 10 September 2014 the Company bought 3800 own shares representing 0.0029% of the share capital of the Company, to the total value of 15 868.8 BGN on the Bulgarian Stock Exchange, the average price per share was 4.18 BGN.
The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.
The total number of treasury shares after these transactions is 5 075 855, representing 3.85% of the share capital of the Company.
SOPHARMA AD (the “Company”) hereby informs that from 11 September 2014 up to and including 17 September 2014 the Company bought 2 500 own shares representing 0.0019% of the share capital of the Company, to the total value of 10 222.5 BGN on the Bulgarian Stock Exchange, the average price per share was 4.09 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 078 355, representing 3.85% of the share capital of the Company.
SOPHARMA AD hereby informs that from 18 September 2014 up to and including 24 September 2014 the Company bought 7 343 own shares representing 0.0056% of the share capital of the Company, to the total value of 29 212.2 BGN on the Bulgarian Stock Exchange, the average price per share was 3.98 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 085 698, representing 3.85% of the share capital of the Company.
Sopharma AD (the “Company”) notifies that for September 2014 the Company recorded an increase of sales revenues of 3% compared to the same month of 2013, including 6% increase of domestic sales and 2% increase of export sales. During the past nine months Sopharma AD recorded a decrease of sales revenues of 5%, including 3% increase of domestic sales and 8% decrease of export sales compared to the same period of 2013.
SOPHARMA AD hereby informs that from 2 October 2014 up to and including 8 October 2014 the Company bought 14 015 own shares representing 0.011% of the share capital of the Company, to the total value of 56 025.88 BGN on the Bulgarian Stock Exchange, the average price per share was 3.998 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 101 113, representing 3.86% of the share capital of the Company.
SOPHARMA AD hereby informs that from 9 October 2014 up to and including 15 October 2014 the Company bought 1 745 own shares representing 0.0013% of the share capital of the Company, to the total value of 6 955.83 BGN on the Bulgarian Stock Exchange, the average price per share was 3.99 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 102 858, representing 3.87% of the share capital of the Company.
SOPHARMA AD hereby informs that from 16 October 2014 up to and including 22 October 2014 the Company bought 1 819 own shares representing 0.0014% of the share capital of the Company, to the total value of 7 188.11 BGN on the Bulgarian Stock Exchange, the average price per share was 3.95 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 104 677, representing 3.87% of the share capital of the Company.
SOPHARMA AD hereby informs that from 23 October 2014 up to and including 29 October 2014 the Company bought 1 375 own shares representing 0.001% of the share capital of the Company, to the total value of 5389.9 BGN on the Bulgarian Stock Exchange, the average price per share was 3.92 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 106 052, representing 3.87% of the share capital of the Company.
